[GAMUDA] YoY TTM Result on 31-Oct-2019 [#1]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
13-Dec-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2020
Quarter
31-Oct-2019 [#1]
Profit Trend
QoQ- 0.22%
YoY- 46.55%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
Revenue 5,649,000 3,500,378 3,331,089 4,757,009 4,359,119 3,478,345 2,113,985 17.79%
PBT 1,001,415 836,948 508,312 900,653 696,137 879,681 793,755 3.94%
Tax 995,060 -161,115 -149,120 -143,314 -163,108 -180,713 -122,846 -
NP 1,996,475 675,833 359,192 757,339 533,029 698,968 670,909 19.92%
-
NP to SH 1,822,524 631,402 307,348 707,690 482,904 642,962 627,048 19.45%
-
Tax Rate -99.37% 19.25% 29.34% 15.91% 23.43% 20.54% 15.48% -
Total Cost 3,652,525 2,824,545 2,971,897 3,999,670 3,826,090 2,779,377 1,443,076 16.73%
-
Net Worth 11,139,941 9,274,920 8,571,129 8,284,814 7,799,714 7,656,779 7,139,352 7.69%
Dividend
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
Div 1,287,051 150,811 - 296,479 295,675 292,926 289,707 28.20%
Div Payout % 70.62% 23.89% - 41.89% 61.23% 45.56% 46.20% -
Equity
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
Net Worth 11,139,941 9,274,920 8,571,129 8,284,814 7,799,714 7,656,779 7,139,352 7.69%
NOSH 2,591,069 2,513,528 2,513,527 2,473,407 2,468,264 2,455,000 2,420,119 1.14%
Ratio Analysis
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
NP Margin 35.34% 19.31% 10.78% 15.92% 12.23% 20.09% 31.74% -
ROE 16.36% 6.81% 3.59% 8.54% 6.19% 8.40% 8.78% -
Per Share
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
RPS 219.06 139.26 132.53 192.35 176.61 141.74 87.35 16.55%
EPS 70.68 25.12 12.23 28.62 19.56 26.20 25.91 18.19%
DPS 49.91 6.00 0.00 12.00 12.00 12.00 12.00 26.80%
NAPS 4.32 3.69 3.41 3.35 3.16 3.12 2.95 6.56%
Adjusted Per Share Value based on latest NOSH - 2,473,407
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
RPS 200.20 124.05 118.05 168.59 154.49 123.27 74.92 17.79%
EPS 64.59 22.38 10.89 25.08 17.11 22.79 22.22 19.45%
DPS 45.61 5.34 0.00 10.51 10.48 10.38 10.27 28.19%
NAPS 3.948 3.287 3.0376 2.9361 2.7642 2.7136 2.5302 7.69%
Price Multiplier on Financial Quarter End Date
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
Date 31/10/22 29/10/21 30/10/20 31/10/19 31/10/18 31/10/17 31/10/16 -
Price 3.85 3.24 3.33 3.74 2.39 5.25 4.91 -
P/RPS 1.76 2.33 2.51 1.94 1.35 3.70 5.62 -17.58%
P/EPS 5.45 12.90 27.23 13.07 12.22 20.04 18.95 -18.74%
EY 18.36 7.75 3.67 7.65 8.19 4.99 5.28 23.07%
DY 12.96 1.85 0.00 3.21 5.02 2.29 2.44 32.07%
P/NAPS 0.89 0.88 0.98 1.12 0.76 1.68 1.66 -9.86%
Price Multiplier on Announcement Date
31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 31/10/16 CAGR
Date 16/12/22 21/12/21 21/12/20 13/12/19 14/12/18 15/12/17 16/12/16 -
Price 3.61 2.92 3.86 3.78 2.28 4.75 4.81 -
P/RPS 1.65 2.10 2.91 1.97 1.29 3.35 5.51 -18.19%
P/EPS 5.11 11.62 31.57 13.21 11.65 18.13 18.56 -19.33%
EY 19.58 8.60 3.17 7.57 8.58 5.52 5.39 23.97%
DY 13.83 2.05 0.00 3.17 5.26 2.53 2.49 33.05%
P/NAPS 0.84 0.79 1.13 1.13 0.72 1.52 1.63 -10.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment